Sime Darby taking stake in US industrial biotech Verdezyne


KUALA LUMPUR: Sime Darby Bhd is taking a stake in US-based industrial biotechnology company, Verdezyne Inc. to pursue strategic growth areas for its plantation business.

The conglomerate said on Monday a new unit, Sime Darby Renewables under its plantations unit, would spearhead this initiative to focuses on converting traditional and non-traditional palm-based commodities into products of higher value.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Sirim CEO appointed as WAITRO regional representative for 2025/26 term
Asian stocks rise, dollar weak as US yields tick down
Bank Negara, BIS drive global cross-border payment innovation with Project Nexus
China to speed up capital market opening
Hextar Global records higher net profit of RM19.71mil in 3Q
FBM KLCI tracks regional gains
Resorts World Sentosa's casino licence renewed for shorter period due to "unsatisfactory" tourism performance
Malaysia's exports grow 1.6% in Oct 2024
Boeing to lay off over 2,500 workers in US as part of sweeping cuts
Ringgit rises on US dollar correction

Others Also Read